Congress of Clinical Rheumatology Annual Meeting

SAN DIEGO — Although fading from use in vasculitis management strategies, cyclophosphamide still offers several benefits for a minority of patients who are unable to switch to other therapies, according to a presenter at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Although chronic pain impacts more than 100 million patients in the United States, contributing significantly to national medical costs, clinicians continue to struggle with whether pain represents a symptom or the disease itself, according to a presenter at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Rheumatologists should exercise caution when diagnosing patients with suspected vasculitis as several lesser-known diseases can affect the large and medium-sized arteries imitating vasculitis, according to a presenter at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Although patients with dermatomyositis are often advised to use adequate sun protection and prescribed similar therapies as patients with cutaneous lupus, the impact of hydroxychloroquine differs significantly between these two groups, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Taking a ‘holiday’ from many osteoporosis drugs can frequently negate gains in bone density, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Early recognition and targeted, aggressive treatment have led to improved outcomes and fewer hospitalizations in rheumatoid arthritis, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — The use of electromyograms and nerve conduction studies are essential to excluding alternative diagnoses and confirming muscle disease when evaluating patients with suspected myopathic disorders, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Understanding which drugs and drug classes contribute to adverse bone effects, including bone loss and fractures, may be extremely useful for rheumatologists and their patients, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

SAN DIEGO — Increasing use of checkpoint inhibitors in cancer therapy is leading to an uptick in immune-related adverse events for rheumatologists to manage, according to a presentation at the Congress of Clinical Rheumatology West.

SAN DIEGO — As the health care community moves away from opioids for pain management, a number of approaches may be set to fill the gap, according to a presentation at the 2019 Congress of Clinical Rheumatology West.